FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

11 Aug 15

Cancer Genetics Announces Strong Second Quarter 2015 Results (read more...)

- Second Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award (read more...)
10 Aug 15

Cancer Genetics Announces Agreement in Principle to Acquire the Assets of Response Genetics, Inc. and Its Strong Franchise in Solid Tumor Molecular and Genomic Testing (read more...)

- Response Genetics' Los Angeles clinical lab and facility will allow Cancer Genetics to expand its national sales and service footprint and (read more...)

Events

11 Aug 15

2nd Quarter 2015 Conference Call

- Dial-In InformationDomestic: 877-407-4018International: 201-689-8471Conference ID: 13614378(read more...)
02 Jul 15

Clinical Utility & Interpretation of FISH Probes for Effective Diagnosis of Cervical Cancer

04 Jun 15

Jefferies 2015 Global Healthcare Conference

Clinicians
Patients